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In the normal mouse spleen, two distinct populations of dendritic cells (DC) are present that differ in microanatomical location.
The major population of marginal DC is found in the “marginal zone bridging channels” and extends into the red pulp. The
interdigitating cells (IDC) are localized in the T cell areas in the white pulp. The aim of the present study was to characterize these
two splenic DC populations with regard to their phenotype, in vivo phagocytic function, and turnover. Both marginal DC and IDC
are CD11c1 and CD131, but only IDC are NLDC-1451 and CD8a1. Notably, both populations, when freshly isolated, express the
macrophage markers F4/80, BM8, and Mac-1. To study the phagocytic capacity of these cells, we employed the macrophage
“suicide” technique by injecting liposomes loaded with clodronate i.v. Marginal DC, but not IDC, were eliminated by this treat-
ment. Phagocytosis of DiI-labeled liposomes by DC confirmed this finding. The two DC populations differed significantly with
regard to their turnover rates, as studied in a transgenic mouse model of conditional depletion of DC populations with high
turnover. In these mice, marginal DC were completely eliminated, but the IDC population remained virtually intact. From these
data we conclude that the marginal DC population has a high turnover, in contrast to the IDC population. Taken together, the
present results indicate that marginal DC and IDC represent two essentially distinct populations of DC in the mouse spleen. They
differ not only in location, but also in phenotype, phagocytic ability, and turnover. The Journal of Immunology, 1998, 160:
2166–2173.
D endritic cells (DC)3 stand out among the various im-mune accessory cells by their unique ability to activatenaive T lymphocytes. The origin of DC and their rela-
tionship to other leukocytes have remained obscure for a long time.
It was unclear whether DC constituted a separate hemopoietic lin-
eage, or had a myeloid or lymphoid derivation. Recent develop-
ments in this field have indicated that different subpopulations of
DC can be distinguished, having either a myeloid or a lymphoid
origin (recently reviewed in Refs. 1 and 2). It has been shown, for
instance, that thymic DC and T lymphocytes share a common pre-
cursor, which has lost the ability to generate myeloid and erythroid
cells (3). On the other hand, multiple studies now support the view
that monocytes can give rise to DC by appropriate cytokine- or
hormone-stimulated culture (4–6). Different functions have been
attributed to myeloid vs lymphoid DC: the former are ultimate
immunostimulating cells (7), whereas lymphoid DC, in the mouse
marked by CD8a expression, suppress immune responses by in-
ducing apoptosis of CD41 T cells or limiting IL-2 production by
CD81 T cells (8, 9).
In the mouse spleen, two subpopulations of DC have been
shown in anatomically distinct locations. A minor population of
so-called interdigitating cells (IDC) is located in the white pulp T
cell zone, the inner periarteriolar lymphocyte sheath, and a larger
population of marginal DC is found at the border of marginal zone
and splenic red pulp (10). The IDC population was described more
than two decades ago (11) and was thought to be the primary
stimulating cell type in T cell responses. More recently, the larger
marginal DC population was identified (10, 12). It was recognized
that these cells, constituting about 75% of isolated spleen DC, may
be held responsible for most of the stimulating activities of splenic
DC measured in in vitro assays. It remains unclear at present how
this stimulating function may be exerted in vivo, since marginal
DC are not located in the area where T cell responses are thought
to take place. Related to this, questions also remain concerning the
ability of DC to take up Ag, especially in vivo. Based on early in
vitro studies, the endocytic ability of DC was thought to be very
limited (reviewed by Steinman and Swanson, Ref. 13). However,
later it was recognized that in vitro monocyte-derived DC have
significant macropinocytic activity (14). In mouse bone marrow
(BM) cultures, immature stages of DC development were found to
phagocytose particles, including bacteria. This activity is lost upon
terminal maturation of DC (15). Information about in vivo phago-
cytic activity of DC or their precursors is scarce, although recently
rat hepatic lymph DC were shown to internalize i.v.-injected car-
bon or latex particles (16).
In a previous study, we described the DC expression of amino-
peptidase N/CD13, recognized by mAb ER-BMDM1 (17). Others
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found this enzyme to be a marker for APC, and recently it was
implicated in the extracellular trimming of MHC-bound peptides
(18, 19). In addition to the classic IDC in the white pulp, a pop-
ulation of nonlymphocytic cells located in patches at the border of
marginal zone and red pulp was recognized by ER-BMDM1 (17).
On the basis of their expression of genuine macrophage markers
such as F4/80 and BM8, detected by immunofluorescence double
labeling, we then suggested the designation of the latter cells as
“marginal red pulp macrophages.” In the present study, we com-
pared splenic DC and CD131/ER-BMDM11 marginal red pulp
macrophages with respect to their phenotype and phagocytic func-
tion. We also compared their turnover, using a model for condi-
tional depletion of DC, based on the selective expression in DC of
herpes simplex thymidine kinase in a transgenic mouse (20, 21).
Treatment of these HIV-1 long terminal repeat-herpes simplex vi-
rus type 1 thymidine kinase (LTR-TK) transgenic mice, or mice
made chimeric after engraftment of transgenic BM, with ganciclo-
vir (GCV) specifically induces killing of DC, which actively syn-
thesize DNA, but not of resting DC.
We show that the CD131/ER-BMDM11 marginal red pulp
macrophages are actually identical to the previously identified
marginal DC. These cells are essentially distinct from the splenic
white pulp IDC. Marginal DC are able to phagocytose particulates
in vivo, express markers characteristic of both DC and macro-
phages, and have a high turnover. In contrast, IDC are not phago-
cytic in vivo and have slow turnover.
Materials and Methods
Mice
C57BL/6 mice were used between 6 and 20 wk of age. In some DC iso-
lation experiments, C57BL/10 mice (20 wk of age) were used with similar
results. Mice were kept under clean conditions (specific pathogen free,
grade 5). Animals were killed by CO2 exposure and spleens were removed
for cell isolation or histology.
Derivation of HIV1-LTR/HSV1-TK transgenic mice (abbreviated as
LTR-TK mice) has been described (20). These mice, originally (C57BL 3
DBA/2)F2, were back-crossed to a DBA/2 genetic background. LTR-TK
BM chimeric mice were generated by lethal irradiation (1200 rad g-irra-
diation) of 8-wk-old male DBA/2 mice and subsequent transfer of BM cells
from LTR-TK transgenic mice. Four months after BM transplantation, chi-
meric mice were treated with GCV (see below) or sham-treated during 7
days and then killed by decapitation. BM chimeric mice were used, as they
do not show the toxic side effects from GCV treatment seen in LTR-TK
transgenic mice, due to a leakiness of TK expression in nonhemopoietic
cells (21). Mice were treated and used in agreement with institutional
guidelines.
mAbs and conjugates
Abs against DC (N418/CD11c, NLDC-145/DEC-205, 53-6.7.2/CD8a) and
macrophages (BM8, F4/80, MOMA-1, ER-BMDM1/CD13, M1/70/Mac-
1/CD11b) have been described in more detail elsewhere (22, 23). Abs RA3
6B2/B220/CD45R and KT3/CD3 detect B and T cells, respectively (24,
25). mAbs were applied as supernatants from hybridoma cultures or as
optimal dilutions after purification (BM8; kindly provided by Biomedicals
AG, Augst, Switzerland). Hybridomas were obtained from the original
producers or American Type Culture Collection (Rockville, MD).
As second-stage reagents we used: anti-rat Ig and anti-hamster Ig con-
jugated to peroxidase (Jackson ImmunoResearch Laboratories, West
Grove, PA), anti-rat Ig and anti-hamster Ig conjugated to FITC (Cappel,
Organon Teknika, Turnhout, Belgium and Caltag Laboratories, San Fran-
cisco, CA, respectively), and anti-rat Ig conjugated to phycoerythrin (Caltag).
Liposome preparation and in vivo application
Multilamellar liposomes containing clodronate (dichloromethylene
bisphosphonate, a gift from Boehringer Mannheim GmbH, Mannheim,
Germany) in the aqueous phase or the fluorescent dye DiI (Molecular
Probes, Eugene, OR) in the lipid phase were prepared as described previ-
ously (26, 27). Liposomes consisted of phosphatidyl choline and choles-
terol in 6:1 molar ratio. After washing, the liposomes were resuspended in
PBS, and a volume of 0.2 ml, containing about 2 mg of liposome-entrapped
clodronate in case of macrophage-depleting liposomes, was injected via the
tail vein. After 18 h (DiI-liposomes) or 2 days (clodronate-liposomes),
mice were killed and spleens were removed.
Immunohistochemistry
Preparation and staining of cryostat sections for single markers were per-
formed essentially as described before (28). Briefly, 5-mm spleen sections
were cut from OCT compound-embedded blocks, air dried, and stored at
220°C until use. After thawing, sections were fixed with p-rosaniline and
subsequently incubated with mAb and optimally diluted peroxidase-la-
beled secondary Ab supplemented with 2% normal mouse serum. Sections
were washed between steps with PBS supplemented with 0.05% Tween-
20. Ab binding was visualized using NiSO4-supplemented diaminobenzi-
dine as substrate, yielding a black reaction product. Sections were coun-
terstained with nuclear fast red, dehydrated, and embedded in Entellan
(Merck, Darmstadt, Germany).
Adaptation for immunohistochemical double labeling was as follows:
sections were sequentially incubated with N418 hamster anti-mouse mAb,
peroxidase-conjugated anti-hamster Ig, rat anti-mouse mAb, and finally
goat anti-rat Ig-alkaline phosphatase (Southern Biotechnology, Birming-
ham, AL). Alkaline phosphatase activity was visualized first in a 30-min
incubation in the dark using naphtol ASMX phosphate (Merck) and Fast
Blue BB base (Merck) (final concentration of both, 0.025% in 200 mM
Tris-HCl, pH 8.5) as substrate and complexing agent, respectively. Le-
vamisole (0.024%) was added to the reaction mixture to block endogenous
alkaline phosphatase activity. After washing the sections in tap water and
PBS-Tween, 3-amino-9-ethylcarbazole (0.05% in 100 mM acetate buffer,
pH 4.6, supplemented with 0.03% H2O2) was used in a 30-min incubation
to detect peroxidase activity. Next, the sections were rinsed with PBS-
Tween, embedded in Kaisers Glyceringelatin (Merck), and coverslipped. In
these preparations, alkaline phosphatase activity yields a blue reaction
product, whereas peroxidase activity appears red.
Spleen cell and DC isolation and culture
Spleens were cut into small pieces and incubated for 1 h at 37°C with 130
U/ml collagenase III (Worthington Biochemical, Freehold, NJ) and 0.1
mg/ml DNase I (Boehringer Mannheim) in RPMI/25 mM HEPES/penicil-
lin/streptomycin (RPMI-HA). We have chosen for this procedure, instead
of mechanical disruption in the cold, as it provides a significantly higher
yield of splenic DC and macrophages. Control experiments have indicated
that DC isolated by either procedure are similar. The resulting digested
tissue suspension was teased through a 100-mm filter and centrifuged.
Next, erythrocytes were lysed by resuspending the cell pellet in 17 mM
Tris-HCl, pH 7.2, containing 144 mM NH4Cl and incubating this for 10
min on ice. Subsequently, the cell suspension was washed with RPMI-HA
supplemented with 10% FCS (RPMI-HA-FCS) and resuspended. Part of
this suspension was used for flow cytometric analysis and referred to as
“fresh total spleen cells.” The rest of the cells were cultured overnight at
37°C and 5% CO2 in plastic tissue culture flasks. Next, the nonadherent
cells were collected, centrifuged, and resuspended in RPMI-HA-FCS at 1
to 2 3 107 cells per ml (referred to as “overnight total spleen cells”). For
DC enrichment, aliquots of 2 ml of this cell suspension were layered on top
of 2 ml of Nycodenz (Nycomed Pharma AS, Oslo, Norway) (14.5% in
RPMI-HA-FCS) and centrifuged for 20 min at 530 3 g. The interface was
collected and routinely contained 60 to 80% N418high cells.
Immunofluorescence labeling and flow cytometric analysis
Labeling and subsequent phenotypic analysis of spleen cells by flow cy-
tometry were performed essentially as described before (29). Data were
collected using a FACScan (Becton Dickinson, Sunnyvale, CA) and
CellQuest software. Resulting data files were further processed for presen-
tation using WinMDI (accessible at http://facs.scripps.edu/).
Conditional elimination of DC in LTR-TK BM chimeric mice
To deplete LTR-TK-expressing DC in BM chimeric mice (see above),
these mice received 50 mg of GCV/kg body weight/day using a minios-
motic Alzet pump (Alza Corp., Palo Alto, CA) as described (20). Control
mice were sham treated. After 7 days, the mice were killed and spleens
were isolated. Efficacy of GCV on LTR-TK transgenic BM was verified by
inhibition of granulocyte macrophage-CSF-induced DC generation in BM
cultures.
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Results
Mouse spleen contains two CD131 populations of DC in
anatomically distinct locations
Previously, we have found that the CD13 mAb ER-BMDM1
detects two major populations of nonlymphocytic cells in
mouse spleen: IDC in the T cell areas and “marginal red pulp
macrophages” in patches at the periphery of the splenic mar-
ginal zone (17). To investigate a possible identity of these mar-
ginal red pulp macrophages with the marginal DC population
identified by Agger et al. (10), we labeled serial spleen sections
with ER-BMDM1/CD13 and N418/CD11c. Figure 1, a and b,
shows that indeed both mAb detect the same populations. Im-
munohistochemical double labeling further advanced the notion
that ER-BMDM1 and N418 recognize the same DC popula-
tions, i.e., both IDC in the T cell zone and the marginal DC,
which are located adjacent to the marginal zone and extend into
the red pulp (data not shown). Also, a minor population of cells
scattered in the red pulp is labeled by both mAb. In contrast,
NLDC-145 only recognizes the population of IDC in the white
pulp (Fig. 6c). Double labeling of spleen sections with N418
and various anti-macrophage mAb indicated that the marginal
DC accumulate at sites where the continuous rim of marginal
zone and metallophilic macrophages is interrupted by the so-
called marginal zone bridging channels (Fig. 2a). These chan-
nels, which are more apparent in rat than in mouse spleen, are
also visible as slight accumulations of T cells and interruptions
of the marginal zone B cell rim (Fig. 2, c and d). Double la-
beling with BM8 (Fig. 2b) showed that red pulp macrophages
and marginal DC are essentially distinct populations: only few
N4181 marginal DC show traces of BM8 labeling.
FIGURE 1. Splenic DC comprise two populations, both expressing CD13 and CD11c Ags. Serial spleen sections stained with (a) ER-BMDM1/CD13
and (b) N418/CD11c show that both mAb detect the same DC populations: a smaller population of IDC in the T cell zone of the white pulp (wp) and a
larger population of marginal DC extending from the marginal zone into the red pulp area. Original magnification, 3135.
FIGURE 2. Marginal DC are located in the marginal zone bridging channels, interrupting the marginal zone and the rim of marginal metallophilic
macrophages. Immunohistochemical double labeling of near-serial sections shows the spatial relationship between: in red (N418), marginal DC; and in blue
(a), marginal metallophilic macrophages (MOMA-1); (b) red pulp macrophages (BM8); (c) T cells (KT3); (d) B cells (RA3 6B2). Marginal DC are
primarily located at the sites where the marginal zone is interrupted by the marginal zone bridging channels, indicated by the discontinued rim of
metallophilic macrophages and marginal zone B cells, and slight accumulation of T cells. Original magnification: 3135.
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Thus, CD13 mAb ER-BMDM1 detects both CD11c1 DC
populations in spleen: IDC in T cell areas and marginal DC,
which accumulate in the marginal zone bridging channels and
extend into the red pulp area.
Splenic DC express both DC and macrophage markers
The conclusion reached above, that the previously defined mar-
ginal red pulp macrophages are in fact DC, is in seeming conflict
with the observation, made by immunofluorescence double label-
ing, that these cells express multiple markers characteristic of mac-
rophages (17). To respond to this controversy, we analyzed the
phenotype of splenic DC by flow cytometric double labeling in
fresh whole spleen cell suspensions, after overnight culture, and
after subsequent DC enrichment (Fig. 3). DC were identified by
N418 labeling. In accordance with previous reports (30–32),
freshly isolated splenic DC were found to express high levels of
MHC class II, which further increased during overnight culture.
Also, CD13/ER-BMDM1 was uniformly present on fresh and cul-
tured cells. In contrast, splenic DC showed heterogeneous labeling
for NLDC-145 and CD8a: for both markers, only about 25% of
freshly isolated cells was positive. Overnight culture increased
NLDC-145 labeling of both populations, thus retaining their dis-
tinction. Similarly, both populations remained distinct upon cul-
ture with respect to the expression of CD8a. These results confirm
previous findings and show that our procedures generate similar
populations to those obtained by others. Remarkably, with regard
to macrophage markers, freshly isolated spleen DC were found to
be uniformly positive for F4/80 and BM8, as well as for Mac-1.
Both F4/80 and BM8 expression decreased upon culture, whereas
Mac-1 expression was retained. Taken together, these findings in-
dicate that freshly isolated splenic DC express markers character-
istic of DC as well as macrophage markers. Upon culture, expres-
sion of some of the latter decreases, whereas expression of some
typical DC markers is enhanced.
Marginal DC are phagocytic in vivo
The finding that freshly isolated splenic DC express genuine mac-
rophage markers raises the question of whether these cells also
display macrophage functions in vivo, especially phagocytosis of
particulate matter. To test this, we injected mice i.v. with lipo-
somes loaded with clodronate. These liposomes are endocytosed
by phagocytic cells only, and, when applied i.v., eliminate splenic
red pulp macrophages, marginal zone macrophages, and marginal
metallophils (27). Figure 4 confirms that red pulp macrophages,
detected by BM8 labeling, are indeed eliminated 2 days after li-
posome application (Fig. 4b). In addition, marginal zone macro-
phages and metallophils were depleted (not shown). Using N418
and ER-BMDM1 to detect DC in these sections, we found that
marginal DC are completely abolished, whereas IDC appear un-
affected by clodronate-liposome treatment (Fig. 4, d and f ). Also,
the small population of DC scattered throughout the red pulp is
eliminated by this procedure. These findings suggest that marginal
DC and red pulp DC are eliminated due to phagocytosis of clo-
dronate-liposomes. Alternatively, the severe damage caused by de-
pletion of red pulp and marginal zone macrophages may cause
migration of DC. To check this possibility, we i.v. injected lipo-
somes, now labeled with the fluorescent dye DiI instead of loaded
with clodronate. After approximately 18 h, total spleen cell sus-
pensions were prepared and analyzed by flow cytometry to identify
cells that had phagocytosed DiI-liposomes. Figure 5 shows that, on
average, almost half of the CD11c1 DC was DiI positive, indic-
ative of their phagocytosis of liposomes. Interestingly, the inten-
sity of fluorescence of DC was only three- to fourfold lower com-
pared with that of the genuine F4/80high macrophages. From these
FIGURE 3. Freshly isolated spleen DC express both DC and macro-
phage markers, and down-regulate some of the latter upon maturation in
overnight culture. Flow cytometrically determined phenotypes of freshly
isolated or overnight cultured total spleen cells and dendritic cells enriched
by density gradient centrifugation after overnight culture are shown. DC
are identified by N418 staining. The small population of isolated genuine
macrophages, which are F4/80highN4182/low, is indicated in the N418/
F4/80 plot. Fluorescence profiles of samples stained with isotype control
mAb are indistinguishable from those obtained with the second step only
(top panel), thus showing the specificity of the observed labeling. To check
for a potential effect on the DC phenotype of the currently used 1-h incu-
bation period during isolation of fresh spleen cells, we compared these with
DC in spleen cell suspensions obtained by mechanical disruption only and
found them to be phenotypically identical.
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results, we conclude that splenic marginal DC, in addition to their
expression of macrophage markers, also display actual phagocytic
activity in vivo. In support of this, in a 60-min in vitro phagocy-
tosis assay using FITC-labeled Listeria, we found that about 30%
of ER-BMDM11 DC in a freshly isolated spleen cell suspension
were able to internalize bacteria (data not shown). IDC probably
are not phagocytic, as they are not affected in the clodronate-lipo-
some-treated mice. It should be considered, however, that the mi-
crocirculation in the splenic white pulp allows only limited access
of the IDC to i.v. injected liposomes.
Marginal DC are selectively eliminated upon GCV treatment of
LTR-TK BM chimeric mice
To delineate further the presumed distinction between the two
splenic DC populations, we asked whether these subsets differed
significantly in turnover. We approached this question in a trans-
genic mouse model for conditional DC depletion (20). Previously,
in these LTR-TK transgenic mice, a severe depletion of DC was
observed in various organs after only 7 days of treatment with
GCV. Such a brief depletion time is indicative of a high population
turnover, as only TK-expressing cycling cells are affected by this
treatment. In the current study, we used an improved model, real-
ized by generating chimeras with LTR-TK transgenic BM (21).
From Figure 6 it is evident that N4181ER-BMDM11 marginal DC
are completely eliminated by 7-day GCV treatment of LTR-TK
chimeras (Fig. 6, a and b). In contrast, the NLDC-1451 IDC pop-
ulation in these mice is hardly affected (Fig. 6, c and d). In GCV-
treated mice, red pulp macrophages as well as marginal zone mac-
rophages and marginal metallophils are still present, thus
supporting the selective elimination of marginal DC on the basis of
their expression of TK and high turnover (data not shown). Thus,
from these experiments we conclude that marginal DC have a sig-
nificantly higher turnover compared with IDC.
Discussion
In the present study, we have investigated the characteristics of
two populations of DC in the mouse spleen: the classic IDC in the
white pulp T cell area, and the marginal DC, located in the mar-
ginal zone bridging channels and extending from the marginal
zone into the red pulp. Both populations express aminopeptidase
N/CD13, recognized by ER-BMDM1 mAb, as well as CD11c.
Thus, the previously identified CD131 marginal red pulp macro-
phages (17) are identical to the marginal DC. Further phenotypic
FIGURE 4. Spleen marginal DC, but not IDC, are depleted by in vivo application of clodronate-liposomes. Spleen sections from 48-h previously
placebo-treated (a, c, e) or clodronate-liposome-treated (b, d, f ) mice were stained using BM8 (a, b), detecting red pulp macrophages; ER-BMDM1 (c,
d), detecting both marginal DC and IDC; and N418 (e, f ), also detecting both DC populations. Marginal DC populations are indicated in (c) and (e).
Original magnification: 3135.
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analysis of splenic DC has shown that freshly isolated marginal
DC, as well as IDC, express significant levels of typical macro-
phage markers. In addition, the marginal DC population is phago-
cytic in vivo, as indicated by their depletion by clodronate-lipo-
somes and the ability to accumulate fluorescent dye from DiI-
labeled liposomes. For the IDC population, we found no
indications that point to in vivo phagocytic activity. A further dis-
tinction between the two DC populations is substantiated by the
finding that marginal DC, but not IDC, are depleted by GCV in
LTR-TK BM chimeric mice, indicative of the high turnover rate of
only the marginal DC population.
Our findings on the splenic DC marker profiles confirm and extend
previous reports on splenic DC phenotypes (30–33). Not only mar-
ginal DC but also IDC, when freshly isolated, express markers
thought to be characteristic of macrophages, such as F4/80, BM8, and
Mac-1/CD11b when Ab binding is assessed by flow cytometry. Using
less sensitive immunohistology, however, a clear distinction can be
detected between the red pulp macrophages, which express high lev-
els of F4/80 and BM8, and the DC, which express lower levels of
these markers. This is in agreement with previous findings (12). Upon
overnight culture, DC undergo a maturation step and show decreased
binding of F4/80 and BM8 mAb, whereas the DC markers, MHC
class II and NLDC-145, are increasingly expressed. With respect to
the latter, now cells originating from the marginal DC population also
become NLDC-1451, but the two populations still are recognized as
separate and discrete. In accordance with recent findings, we observe
CD8a expression by only a subpopulation of DC (3, 31, 32). This
subset corresponds quantitatively to the NLDC-1451 population over
a range of frequencies (compare this study with Refs. 3 and 31), and
in freshly purified splenic DC it was recently shown that NLDC-145
and CD8a are expressed by the same cells (32). Based on this, IDC
FIGURE 5. Spleen DC and macrophages similarly phagocytose DiI-la-
beled liposomes in vivo. Representative flow cytometric dot plots are
shown of isolated total spleen cells from mice that had been injected with
PBS (a, c) or with DiI-liposomes (b, d) 18 h previously. Samples were
stained for CD11c and F4/80 to detect DC and macrophages, respectively.
Figures in (b) and (d) give mean percentages 6 SD obtained from three
individual mice as determined in a single experiment. This experiment was
repeated three times with similar results.
FIGURE 6. Marginal DC, but not IDC, are depleted in GCV-treated LTR-TK BM chimeric mice. Spleen sections from GCV-treated (a, b, d) and
sham-treated (c) LTR-TK BM chimeric mice were stained for the presence of DC using ER-BMDM1/CD13 (a), N418/CD11c (b), and NLDC-145 (c, d).
a and b represent serial sections; c and d are from different but comparably representative locations, showing white and red pulp areas. ER-BMDM1 and
N418 staining patterns of spleens from sham-treated animals and untreated mice (represented in Fig. 1, a and b, respectively) are identical. GCV treatment
of LTR-TK BM chimeric mice induces almost complete elimination of ER-BMDM11N4181 marginal DC (a, b), indicating their high turnover, whereas
NLDC-1451 IDC are hardly affected (compare c and d). Original magnification: 3135.
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are the most likely candidates for the CD8a1 subset of DC (31, 32),
leaving the marginal DC as the CD8a2 subset. The latter was indeed
confirmed by immunohistology (our unpublished observations). It
cannot be excluded, however, that some cells with a marginal DC
phenotype are located in the white pulp also under steady-state con-
ditions, as was observed after LPS administration (34).
Expression of a number of genuine macrophage markers by
splenic DC prompted us to investigate the ability of these cells to
phagocytose particles as a typical function of macrophages. We
have chosen to use relatively large multilamellar phosphatidylcho-
line liposomes as model particles since numerous previous studies
have shown that these agents have a high selectivity for macro-
phages in vivo and, when loaded with clodronate, can be used for
selective elimination of phagocytic cells (27, 35, 36). Based on the
actual depletion of marginal DC by clodronate-liposomes and the
observed labeling of isolated DC after application of DiI-carrying
liposomes, we conclude that at least a subset of DC is phagocytic
in vivo. In support of this finding, recent studies in the rat have
shown that i.v. applied particulates can be phagocytosed in vivo by
DC (16). These cells were detected in hepatic lymph, but the site
of actual phagocytosis remained unclear. At least part of the
phagocytic DC was suggested to have migrated from the spleen to
the liver into hepatic lymph, and in line with this, we propose that
the marginal DC are the most likely candidates. Interestingly, mi-
gration studies have shown preferential homing of the majority of
isolated splenic DC to the liver (37).
The elimination of marginal DC after phagocytosis of clodr-
onate-liposomes occurs in all likelihood by apoptosis of these
cells. Recent studies have shown that accumulation of clodronate
encapsulated in multilamellar liposomes is a trigger for the apo-
ptotic pathway in activated human monocytes and mouse macro-
phages (36, 38, 39). Not all cell types, however, that incorporate
liposomes seem to die. In vitro application showed that, in addition
to monocytes, polymorphonuclear cells and endothelial cells also
take up liposomes, but these cells do not undergo apoptosis (39).
Elimination is only accomplished in cells 1) in which a sufficiently
high threshold of clodronate is reached, and 2) that possess the
lysosomal machinery to cleave the liposome membranes and so
release their content. These requirements are only met in activated
monocytes, macrophages, and macrophage cell lines. Our finding
that marginal DC are also depleted by uptake of clodronate-lipo-
somes implies that these cells not only phagocytose at a sufficiently
high level, but also possess the required lysosomal activity to break
down the liposomes. Thus, in addition to the phenotypic resem-
blance, these features support the view that the marginal DC are
closely related to the macrophage lineage.
The capacity of marginal DC to phagocytose is likely indicative
of the relative immaturity of these cells. In vitro-proliferating BM
progenitors of DC have been shown to phagocytose latex and bac-
teria, but lose this capacity upon maturation (15). In addition, the
in vivo phagocytic DC, detected in liver and hepatic lymph after
i.v. application of particulates, are derived from recently divided
precursor cells (16). Furthermore, the mouse precursor DC cell
lines XS52 and FSDC show avid pinocytosis and phagocytosis,
which is suppressed when the cells are stimulated to mature (40,
41). Maturation of DC is induced by cytokines such as IFN-g,
IL-1, granulocyte macrophage-CSF, and TNF, which in vivo are
likely produced by T cells and macrophages, communicating with
the immature DC (41–43). Thus, phagocytosis by marginal DC,
like endocytosis by DC in general, is most likely an immature
trait (13).
Immaturity of the marginal DC is underlined by our finding that
these cells are depleted in GCV-treated chimeric LTR-TK mice.
Depletion in this system is based upon the termination of elongat-
ing DNA by a phosphorylated form of the nucleoside analogue
GCV (44). Initial phosphorylation occurs by the Herpes simplex
thymidine kinase. Thus, actual depletion is only observed in those
cells that synthesize DNA and express the TK transgene, i.e., do-
nor BM-derived DC. So, either the marginal DC themselves or
their immediate precursors multiply, while these cells are retained
in the marginal location only for a short period of time. Remark-
ably, IDC were hardly affected in these mice, indicating that these
cells have a much slower turnover rate. Such a dichotomy between
DC subsets has been suggested before (7), although limited exper-
imental evidence has been provided.
The question then arises whether the “immature” marginal DC
are the precursors of “mature” IDC, as has been suggested (10).
Culture of freshly isolated DC, i.e., primarily marginal DC, indeed
induces expression of NLDC-145 and M342 Ags, typical for IDC
(Fig. 3 and Refs. 10 and 32). In addition, isolated splenic DC can
home to the white pulp T cell zones when injected i.v. (45). Fur-
thermore, in vivo administration of LPS induces maturation of
marginal DC, concomitant with their migration into the T cell ar-
eas (34). Some observations, however, challenge a putative pre-
cursor-endstage relationship between marginal DC and IDC under
steady-state conditions. As demonstrated in our results, a clear
phenotypic distinction remains between the two populations of DC
upon culture, despite the induction of NLDC-145 Ag expression in
marginal DC. And, as mentioned before, the majority of isolated
splenic DC homes to the liver, whereas the minority homing to the
splenic T cell areas might represent the population originally iso-
lated from this location. In addition, CD8a also seems to be a
stable determinant discriminating between the two populations, as
it is present only on IDC. It has been proposed that CD8a is a
marker for DC of lymphoid origin, rather than of myeloid deriva-
tion (3, 31, 32). In contrast, the marginal DC bear all characteris-
tics of a myeloid origin and close relationship to macrophages, as
is apparent from their elimination by clodronate-liposomes. A dif-
ferent lineage derivation of marginal DC and IDC, although for-
mally not proven, is clearly incompatible with a precursor-end-
stage relationship between these cells.
Both DC populations seem to play fundamentally distinct roles
in the regulation of T cell responses. CD8a1, presumed lymphoid,
DC have recently been shown to kill Ag-specific CD41 T cells via
Fas-Fas ligand interaction. These cells can stimulate a prolonged
CD81 T cell response only if exogenous IL-2 is present (8, 9). In
contrast, CD8a2, presumed myeloid, DC are the classic profes-
sional initiators of both CD41 and CD81 T cell responses. In this
respect, it is an intriguing notion that the stimulating, myeloid DC
are located outside the classic splenic T cell area, yet are in the
migration pathway of homing T cells, namely in the marginal zone
bridging channels (46, 47). In line with this, activated T cells ex-
pressing CD40L have been found in immunized spleen only near
the terminal arteriole, compatible with the location of the marginal
DC, but not in the T cell area of the white pulp (48). A hypothetical
scenario thus might be that circulating T cells are activated outside
the splenic white pulp upon recognition of cognate Ag presented
by myeloid DC, and then move into the periarteriolar lymphoid
sheath, either or not accompanied by the maturing myeloid DC. In
the T cell areas then, the T cell response is finalized, tightly bal-
anced by the regulatory, lymphoid DC.
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